Thermic Sciences International
US ˙ OTCPK ˙ US29271J1097

Introduction

This page provides a comprehensive analysis of the known insider trading history of Chad Steven Johnson. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Chad Steven Johnson has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:CBIS / Cannabis Science, Inc. Secretary/COO/General Counsel, Director 17,420,323
US:ENDO / Thermic Sciences International C.O.O., General Counsel, Director 15,000,000
US:IMCL / Immunoclin Corporation Secretary/COO/General Counsel, Director 2,000,000
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Chad Steven Johnson. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ENDO / Thermic Sciences International - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ENDO / Thermic Sciences International. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ENDO / Thermic Sciences International Insider Trades
Insider Sales ENDO / Thermic Sciences International - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ENDO / Thermic Sciences International. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ENDO / Thermic Sciences International Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Chad Steven Johnson as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2016-04-01 2016-03-31 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -500,000 17,420,323 -2.79 0.02 -11,900 414,604
2016-04-01 2016-03-31 4 CBIS CANNABIS SCIENCE, INC.
Series A Preferred Stock
S - Sale -200,000 17,920,323 -1.10 0.02 -4,560 408,583
2016-03-30 2016-03-29 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -402,000 18,120,323 -2.17 0.02 -7,960 358,782
2016-03-30 2016-03-28 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -2,000,000 18,522,323 -9.75 0.02 -45,600 422,309
2016-03-23 2016-03-23 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
A - Award 20,000,000 20,522,323 3,829.05 0.01 216,000 221,641
2016-03-23 2016-03-23 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
G - Gift -400,000 522,323 -43.37
2016-03-22 2016-03-21 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -483,852 922,323 -34.41 0.02 -8,129 15,495
2016-03-03 2016-03-03 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -660,000 1,406,175 -31.94 0.01 -6,930 14,765
2016-03-03 2016-03-02 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -664,000 2,066,175 -24.32 0.01 -7,238 22,521
2016-03-03 2016-03-02 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -300,000 2,730,175 -9.90 0.01 -3,210 29,213
2016-03-03 2016-03-01 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -564,334 3,030,175 -15.70 0.01 -6,208 33,332
2016-02-29 2016-02-29 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -500,000 3,594,509 -12.21 0.01 -5,800 41,696
2016-02-29 2015-02-26 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -3,100,000 4,094,509 -43.09 0.01 -35,960 47,496
2016-02-29 2015-02-25 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -770,000 7,195,509 -9.67 0.01 -8,701 81,309
2016-02-22 2016-02-09 4 ENDO OMNICANNA HEALTH SOLUTIONS, INC.
Common Stock
A - Award 5,000,000 15,000,000 50.00 0.00 21,500 64,500
2016-02-22 2016-01-19 4 ENDO OMNICANNA HEALTH SOLUTIONS, INC.
Common Stock
A - Award 5,000,000 10,000,000 100.00 0.01 71,000 142,000
2016-02-22 2016-02-19 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -365,300 7,894,509 -4.42 0.01 -4,493 97,102
2016-02-22 2015-02-18 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -1,400,000 8,259,809 -14.49 0.01 -17,360 102,422
2015-12-15 2015-12-11 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -1,646,142 9,659,809 -14.56 0.02 -26,832 157,455
2015-12-07 2015-12-03 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -769,986 11,305,951 -6.38 0.02 -13,398 196,724
2015-12-03 2015-12-02 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -600,000 12,075,937 -4.73 0.02 -10,740 216,159
2015-12-03 2015-12-01 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -1,252,239 12,675,937 -8.99 0.02 -23,542 238,308
2015-08-24 2015-05-04 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
A - Award 10,000,000 13,928,176 254.57 0.04 350,000 487,486
2015-08-20 2015-08-19 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -500,000 3,928,176 -11.29 0.04 -21,350 167,733
2015-08-20 2015-08-18 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -5,000,000 4,428,176 -53.03 0.03 -160,000 141,702
2015-08-20 2015-08-18 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -1,000,000 9,428,176 -9.59 0.03 -33,500 315,844
2015-06-16 2015-06-11 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -94,144 10,428,176 -0.89 0.03 -2,636 291,989
2015-06-10 2015-06-09 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -300,000 10,522,320 -2.77 0.03 -8,460 296,729
2015-06-10 2015-06-08 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -763,575 10,822,230 -6.59 0.03 -21,838 309,516
2015-06-09 2015-06-05 4 IMCL Immunoclin Corp
Common Stock
A - Award 1,000,000 2,000,000 100.00 5.00 5,000,000 10,000,000
2015-05-19 3 ENDO Endocan Corporation.
Common Stock
10,000,000
2015-05-19 3 ENDO Endocan Corporation.
Common Stock
10,000,000
2015-04-29 2015-04-29 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -121,333 11,464,562 -1.05 0.04 -4,441 419,603
2015-04-29 2015-04-28 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -100,000 11,585,895 -0.86 0.04 -3,800 440,264
2015-04-29 2015-04-27 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -700,000 11,685,895 -5.65 0.04 -27,720 462,761
2015-03-30 2015-03-27 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -500,000 12,385,895 -3.88 0.04 -21,650 536,309
2015-03-30 2015-03-26 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -750,000 12,885,895 -5.50 0.04 -33,750 579,865
2015-03-30 2015-03-26 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -150,000 13,635,895 -1.09 0.04 -6,645 604,070
2015-03-20 2015-03-19 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -10,404 13,785,895 -0.08 0.05 -520 689,295
2015-03-20 2015-03-19 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -562,691 13,796,299 -3.92 0.05 -27,572 676,019
2015-03-20 2015-03-18 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -689,596 14,358,990 -4.58 0.05 -33,997 707,898
2015-02-04 2015-02-04 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -809,914 15,048,586 -5.11 0.05 -44,059 818,643
2015-02-04 2015-02-02 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -1,000,000 15,858,500 -5.93 0.06 -55,700 883,318
2015-01-22 2015-01-20 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -255,000 16,858,500 -1.49 0.07 -16,626 1,099,174
2015-01-20 2014-11-21 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -150,000 17,113,500 -0.87 0.07 -10,350 1,180,832
2015-01-15 2015-01-01 4 IMCL Immunoclin Corp
Common Stock Options
A - Award 500,000 500,000 1.45 725,000 725,000
2015-01-06 2015-01-05 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -100,000 17,263,500 -0.58 0.07 -7,400 1,277,499
2015-01-06 2015-01-05 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -500,000 17,363,500 -2.80 0.07 -36,900 1,281,426
2015-01-06 2015-01-02 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -1,000,000 17,863,500 -5.30 0.06 -64,400 1,150,409
2014-11-20 2014-11-20 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -235,000 18,863,500 -1.23 0.07 -16,098 1,292,150
2014-11-20 2014-11-18 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -99,990 19,098,500 -0.52 0.07 -6,799 1,298,698
2014-11-20 2014-11-18 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -99,000 19,198,490 -0.51 0.07 -6,930 1,343,894
2014-11-17 2014-11-14 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -99,000 19,297,490 -0.51 0.07 -6,732 1,312,229
2014-11-17 2014-11-13 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -147,210 19,396,490 -0.75 0.06 -9,156 1,206,462
2014-11-17 2014-11-11 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -4,900 19,543,700 -0.03 0.07 -323 1,289,884
2014-11-05 2014-11-03 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -400,000 19,548,600 -2.01 0.09 -35,400 1,730,051
2014-10-31 2014-10-31 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -50,000 19,998,600 -0.25 0.08 -4,150 1,659,884
2014-10-31 2014-10-31 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -100,000 20,048,600 -0.50 0.08 -8,250 1,654,010
2014-10-31 2014-10-30 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -200,000 20,148,600 -0.98 0.08 -15,000 1,511,145
2014-10-31 2014-10-30 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -200,000 20,348,600 -0.97 0.08 -15,200 1,546,494
2014-10-31 2014-10-30 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale -200,000 20,548,600 -0.96 0.08 -15,680 1,611,010
2014-10-23 2014-10-20 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
A - Award 5,000,000 20,748,600 31.75 0.05 250,000 1,037,430
2014-10-23 2014-10-20 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
A - Award 3,500,000 15,748,600 28.57 0.05 175,000 787,430
2014-10-09 3 IMCL Immunoclin Corp
Common Stock
2,030,000
2014-10-09 3 IMCL Immunoclin Corp
Series A Preferred Stock
1,060,000
2014-10-09 3 IMCL Immunoclin Corp
Common Stock
2,030,000
2014-10-09 3 IMCL Immunoclin Corp
Series A Preferred Stock
1,060,000
2014-09-12 2014-01-14 4 CBIS CANNABIS SCIENCE, INC.
Common Stock
S - Sale 6,151,400 12,248,600 100.89 0.15 909,792 1,811,568
2014-02-20 2014-01-28 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -25,000 6,203,200 -0.40 4,989.78 -124,744,500 30,952,603,296
2014-02-20 2014-01-27 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -225,000 6,228,200 -3.49 34,027.78 -7,656,250,500 211,931,819,396
2014-02-20 2014-01-24 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -75,000 6,453,200 -1.15 10,110.53 -758,289,750 65,245,272,196
2014-02-20 2014-01-23 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -310,000 6,528,200 -4.53 38,696.60 -11,995,946,000 252,619,144,120
2014-02-20 2014-01-22 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -451,000 6,838,200 -6.19 51,356.46 -23,161,763,460 351,185,744,772
2014-02-20 2014-01-21 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -210,800 7,289,200 -2.81 22,673.46 -4,779,565,368 165,271,384,632
2014-02-20 2014-01-16 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -800,000 7,500,000 -9.64 60,726.66 -48,581,328,000 455,449,950,000
2014-02-20 2014-01-15 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -2,500,000 8,300,000 -23.15 216,917.82 -542,294,550,000 1,800,417,906,000
2014-02-20 2014-01-14 4 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
S - Sale -200,000 10,800,000 -1.82 20,038.81 -4,007,762,000 216,419,148,000
2014-02-20 3 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
16,406,400
2014-02-20 3 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
16,406,400
2014-02-20 3 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
22,000,000
2014-02-20 3 CBIS CANNABIS SCIENCE, INC.
COMMON STOCK
22,000,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)